Procerin Review: Does It Actually Work?

Procerin has been on the market for over 20 years — longer than Hims, Keeps, or most of the telemedicine hair loss brands that dominate advertising today. That longevity matters, because most supplement companies don't survive two decades unless something is working. But longevity alone isn't evidence.

This site reviews both Procerin products — the original OTC DHT-blocking supplement (oral capsules + topical activator) and the newer Procerin Rx prescription topical (finasteride + minoxidil blend via telemedicine). We cover the clinical study data, compare Procerin head-to-head against competitors, and include real testimonials from IRB-approved study participants.

We lean pro-Procerin here — because the evidence supports it — but we also cover the limitations honestly. No hair loss product works for everyone, and setting realistic expectations is part of a credible review.

Key Terms Defined

What is Procerin?

Procerin is defined as a two-part over-the-counter hair loss management system — oral capsules and a topical activator — that uses natural 5-alpha-reductase inhibitors to reduce DHT (dihydrotestosterone) levels. It is not a prescription drug, and it is not a cure for hair loss. The term refers to both the original OTC supplement (on the market since 2002) and the broader Procerin product line, which now includes Procerin Rx, a separate prescription topical. Procerin's OTC formula has been evaluated in an IRB-approved, double-blind, placebo-controlled clinical study — a level of evidence uncommon for dietary supplements.

What is DHT (dihydrotestosterone)?

DHT, or dihydrotestosterone, is defined as a potent androgen hormone derived from testosterone through the action of the enzyme 5-alpha-reductase. In genetically susceptible individuals, DHT binds to androgen receptors in scalp hair follicles and triggers a process called follicular miniaturization — where terminal hairs gradually become thinner, shorter, and less pigmented until the follicle produces only fine vellus hair or stops producing visible hair entirely. DHT is the primary hormonal driver of androgenetic alopecia in men. Blocking DHT production or its binding at the follicle level is the mechanism behind most hair loss treatments, both pharmaceutical (finasteride) and natural (saw palmetto, beta-sitosterol).

What is androgenetic alopecia?

Androgenetic alopecia refers to the most common form of progressive hair loss in men, often called male pattern baldness. It is a hereditary condition driven by genetic sensitivity to DHT rather than by elevated DHT levels alone — two men with identical DHT levels can experience very different degrees of hair loss based on their follicle genetics. Androgenetic alopecia typically follows the Norwood scale pattern, beginning with recession at the temples and thinning at the crown, and affects an estimated 50% of men by age 50. It is not a disease — it is a normal variation in hair growth — but it can be managed through DHT-blocking interventions, topical stimulants like minoxidil, or surgical hair transplantation. No treatment is a cure; all require ongoing use to maintain results.